Mar 27, 2026 by Bram BerkowitzDow Tumbles 800 Points and the S&P 500 Posts Its Fifth Straight Weekly Loss: What Investors Need to Know About the Worst Streak Since 2022The market struggled this week amid the ongoing war in Iran.
Mar 27, 2026 by Jeremy BowmanEvery Magnificent Seven Stock Is Down This Year. This One Is a Screaming BuyInvestors are rotating out of the Mag Seven, but there's still opportunity there.
Mar 27, 2026 by Jeremy BowmanOne Magnificent Dividend Stock Down 71%: Too Cheap Not to Buy and Hold ForeverNike stock has collapsed in recent years, but there's a lot of turnaround potential.
Mar 27, 2026 by Jeremy BowmanEvery Magnificent Seven Stock Is Down This Year. This One Is a Screaming BuyInvestors are rotating out of the Mag Seven, but there's still opportunity there.
Mar 27, 2026 by Jonathan PoncianoCurbline CEO Sells $3 Million in Stock as Net Income Jumps to $40 Million. What Should Investors Know?This New York retail REIT, focused on high-traffic shopping centers, reported notable insider selling amid recent sector outperformance.
Mar 27, 2026 by Jeremy BowmanOne Magnificent Dividend Stock Down 71%: Too Cheap Not to Buy and Hold ForeverNike stock has collapsed in recent years, but there's a lot of turnaround potential.
Mar 27, 2026 by Jonathan PoncianoLincoln Educational Insider Sells 8,450 Shares Amid Big Stock Surge, but Here's What Matters for InvestorsKnown for its career-focused education programs, this technical training provider reported a notable insider sale in its latest SEC filing.
Mar 27, 2026 by Joe TenebrusoWhy Six Flags Stock Fell TodayIt's becoming more expensive to drive to amusement parks.
Mar 27, 2026 by Jonathan PoncianoProgress Software EVP Sells 23,194 Shares as Stock Falls 40% Year Over YearThis enterprise software firm, focused on automation and secure connectivity, reported a significant insider sale in the latest filing.
Mar 27, 2026 by Jeremy BowmanMeta Plunges on Jury Verdict. Here's What It Means for InvestorsTwo jury verdicts highlight a new risk facing Meta.
Mar 27, 2026 by Robert IzquierdoAXT's CEO Sold Shares Worth $1.4 Million. Is Now the Time to Sell or Buy the Stock?Specializing in advanced semiconductor substrates, this materials supplier reported a notable insider sale amid ongoing sector demand.
Mar 27, 2026 by Jonathan PoncianoAlpha Metallurgical Insider Purchase Worth $2 Million Comes Just Weeks Before 20% RallyAlpha Metallurgical Resources, a major U.S. coal supplier, reported a recent insider buy following a year of strong stock performance.
Mar 27, 2026 by Jeremy BowmanCarnival Gets Hit By the Iran War. Can the Cruise Stock Bounce Back?Rising oil prices are pressuring the cruise operator.
Mar 27, 2026 by Robert IzquierdoIs Tecnoglass Stock a Buy After Energy Holdings Scooped Up Shares Worth $13.1 Million?This architectural glass manufacturer, serving major markets across the Americas, reported a recent insider buy in official filings.
Mar 27, 2026 by Alex CarchidiEthereum and Solana Just Got a Huge Catalyst. Should You Buy Them With $1,000?These two coins now have fewer obstacles blocking their growth.
Mar 27, 2026 by Jonathan PoncianoStoke Therapeutics Stock Up 340% as Chair Sells $174K in SharesThis biotech innovator in genetic disease therapies reported a notable insider sale amid a year of dramatic share price gains.
Mar 27, 2026 by Jonathan PoncianoThis F&G Insider Spent $100,000 Buying Shares Despite a Steep Stock Plunge. Is It Time for a Turnaround?This annuities and life insurance provider saw a notable insider buy amid a year marked by sharp share price declines and sector headwinds.
Mar 27, 2026 by Catie HoganShould You Buy Lockheed Martin While It's Up 26% in 2026?If the defense budget tops $1 trillion, Lockheed stands to make a fortune.
Mar 27, 2026 by Joe TenebrusoWhy Argan Stock Ascended TodayData centers devour energy. Argan builds the power plants that feed them.
Mar 27, 2026 by Jonathan PoncianoLeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should KnowLeMaitre Vascular, a specialist in vascular medical devices, reported a notable insider sale amid strong recent share gains.
Mar 27, 2026 by Jonathan PoncianoCrinetics Director Sells 5,000 Shares With Stock Down 4%, but Here's What Matters MoreThis biotech specializing in endocrine therapies reported a notable insider sale as it advances clinical-stage drug candidates.
Mar 27, 2026 by Keithen Drury3 No-Brainer AI Stocks to Buy Before They Soar, According to Wall StreetAnalysts think Nebius, Microsoft, and Nvidia have huge upsides.
Mar 27, 2026 by Jonathan PoncianoAlphatec CFO Sells $986K in Stock With Shares Up 9% This Past Year. Here's What Investors Should KnowThis spine-focused medtech firm, known for its surgical innovations, reported a notable insider sale amid ongoing portfolio expansion.
